Delivery Order SPE2DB22D3010-SPE2DB25FP2XX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a $16,914.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $399,725.26 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on September 9, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens valued at $30,993.63, with a firm fixed price structure and no set-aside designation. The award was executed on June 5, 2025, with an ultimate completion date of June 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a $48,739.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award for a single-unit delivery order. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $8,205.18 firm fixed price delivery order for Zepbound 15 mg/0.5 mL pen injectors, with an ultimate completion date of September 9, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role in supplying pharmaceutical products to federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens valued at $9,721.62. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract issued under...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP2XXDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,749.40 for Zepbound 2.5 mg/0.5 ml pens with a completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a major distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities across multiple therapeutic domains to support military healthcare systems and other federal medical programs. The Zepbound delivery aligns with the company's portfolio of specialty medications and demonstrates its role as a key vendor for Department of Defense healthcare procurement needs. DLA has indicated plans to establish the next generation of Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen among the vendors serving Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 7/11/25 |